Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Tocilizumab might be an effective treatment for COVID-19.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

The new AI software predicts melanoma outcomes more accurately than traditional methods.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

Apremilast may help treat hair loss in alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Composite biomaterials can precisely control immune responses for better disease treatment.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

The combination therapy was effective and well-tolerated, especially in young patients.

Adipose-derived stem cell-conditioned medium can reduce melanoma cell growth and spread.

Rituximab can cause skin issues, but baricitinib may help improve them.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

The combination of encorafenib and binimetinib caused few skin issues.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.